Atlas Trials

Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation

Clinical trial NCT01800643 · UNKNOWN

Trial details

NCT number
NCT01800643
Sponsor
Hospital Israelita Albert Einstein
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute LeukemiaChronic LeukemiaLymphoproliferative DiseaseMyeloproliferative DiseaseImmunodeficiency
Start date
2010-03-01
Primary completion
2014-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.